Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2400-2403
Published online before print October 13, 2005, doi: 10.1161/01.STR.0000185698.45720.58
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/11/2400    most recent
01.STR.0000185698.45720.58v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khatri, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khatri, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Angiography
Right arrow Thrombolysis

(Stroke. 2005;36:2400.)
© 2005 American Heart Association, Inc.


Original Contributions

Revascularization End Points in Stroke Interventional Trials

Recanalization Versus Reperfusion in IMS-I

Pooja Khatri, MD; Joddi Neff, MD; Joseph P. Broderick, MD; Jane C. Khoury, MS; Janice Carrozzella, RN; Thomas Tomsick, MD for the IMS-I Investigators

From the Department of Neurology, University of Cincinnati, Ohio.

Correspondence to Pooja Khatri, MD, University of Cincinnati, Department of Neurology, 231 Albert Sabin Way ML 0525, Cincinnati, OH 45267-0525. E-mail Pooja.Khatri{at}uc.edu

Background and Purpose— The acute stroke literature lacks a standard convention regarding the critical end point of revascularization. Two distinct parameters may be clinically important: (1) recanalization of the primary arterial occlusive lesion (AOL) and (2) global reperfusion of the distal vascular bed. We sought to determine their relationship in the Interventional Management of Stroke (IMS) Phase I trial of combined intravenous (IV) and intraarterial (IA) recombinant tissue plasminogen activator.

Methods— Sixty-one angiograms were reanalyzed using recanalization and reperfusion scores. The AOL Score was defined as: 0=no recanalization of the primary occlusion, I=incomplete or partial recanalization of the primary occlusion with no distal flow, II=incomplete or partial recanalization of the primary occlusion with distal flow, or III=complete recanalization of the primary occlusion with distal flow. The Thrombolysis in Myocardial Infarction (TIMI) Score was defined as: 0=no perfusion, 1=perfusion past the initial occlusion but no distal branch filling, 2=perfusion and incomplete or slow distal branch filling, or 3=full perfusion with filling of all distal branches. We compared the 2 scores with one another and with good clinical outcome (modified Rankin Score zero to 2).

Results— AOL and TIMI scores showed modest agreement (kappa, 0.30; confidence interval, 0.16 to 0.44). Good clinical outcome was seen in 49% of patients with AOL II/III scores (P=0.055) and 54% with TIMI 2/3 scores (P=0.019). The 2 methods did not significantly differ in predicting outcome (P=0.13).

Conclusions— AOL recanalization and TIMI reperfusion scores comparably predict clinical outcome in this treatment paradigm. Other modalities may show different relationships between these 2 revascularization end points. Future studies should distinguish between these parameters semantically and methodologically.


Key Words: acute Rx • acute stroke • interventional neuroradiology




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
E.S. Rosenthal, L.H. Schwamm, L. Roccatagliata, S.B. Coutts, A.M. Demchuk, P.W. Schaefer, R.G. Gonzalez, M.D. Hill, E.F. Halpern, and M.H. Lev
Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model
AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1471 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Tomsick, J. Broderick, J. Carrozella, P. Khatri, M. Hill, Y. Palesch, J. Khoury, and for the Interventional Management of Stroke II Inv
Revascularization Results in the Interventional Management of Stroke II Trial
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 582 - 587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. King, P. Khatri, J. Carrozella, J. Spilker, J. Broderick, M. Hill, T. Tomsick, and for the IMS & IIMS II Investigators
Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial rtPA Treatment of Acute Ischemic Stroke in the IMS I and II Trials
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1890 - 1894.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.-H. Sohn, S.-I. Sohn, H.-W. Chang, and A. M. Demchuk
Postcontrast Time-of-Flight MR Angiography Demonstrating Collateral Flow in Acute Stroke
Stroke, April 1, 2007; 38(4): 1132 - 1132.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Tomsick
TIMI, TIBI, TICI: I Came, I Saw, I Got Confused
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 382 - 384.
[Full Text] [PDF]